Clinical Trials Browser

Smoldering Multiple Myeloma × Lymphoid × Clear all

NCT01177527 2025-11-26

Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Lymphoma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT03717844 2025-11-20

Registry for Adults With Plasma Cell Disorders (PCD's)

Recruiting

2,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Multiple Myeloma, POEMS Syndrome

NCT06895291 2025-03-30

ONCO-MRI

Recruiting

1,000 enrolled

LymphoidPlasma cell

Smoldering Multiple Myeloma, Lymphoma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT04023747 2025-02-03

OxPLoreD

Active not recruiting

574 enrolled

LymphoidPlasma cell

Smoldering Multiple Myeloma, Lymphoproliferative Disorders

NCT02298816 2024-10-03

HMvax-Regist

Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Influenza, Human, Lymphocytosis, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Pneumonia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05283993 2022-04-25

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting

2,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, POEMS Syndrome

NCT00919139 2015-04-03

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Completed

190 enrolled

LymphoidPlasma cell

Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT00899353 2013-12-12

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Phase 2 Terminated

16 enrolled 6 charts

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Leukemia, Lymphocytic, Chronic, B-Cell